← Return to What are your 3 worst symptoms?

Discussion

What are your 3 worst symptoms?

Post-COVID Recovery & COVID-19 | Last Active: 2 hours ago | Replies (45)

Comment receiving replies
@gregorb

Looks like you have a handle on the description. Guess we can add it to the quickly growing 200 + other symptoms. Know it won't be the last. Long Covid doesn't discriminate. Lots to choose from. Plenty for everyone. Expecting all illnesses to be diagnosed as long covid related before long.

Jump to this post


Replies to "Looks like you have a handle on the description. Guess we can add it to the..."

In some of Dr. Patterson's talks (on YouTube), he says that "head fullness" is a common symptom of Long COVID. I wouldn't have labeled it "fullness" if I hadn't heard his term, but it might be that the "fullness" is what I call "distortion." Below are some of his comments that I transcribed:

[It won't let me post the link, but the YouTube ID is h2xyWiMS2Q0.]

Dr. Bruce Patterson, founder of IncellDx, in a presentation at
Georgetown University on Diagnosis and Treatment of Long
COVID, Feb. 2022 (at 35:30):

"The other thing is that the fractalkine receptor and binding
of non-classical monocytes results in angiogenesis through
VEGF, which of course we see in all four of these conditions
[Covid long-haulers, ME/CFS, Fibromyalgia, post-vaccination
long-haulers] and vasodilitation. Why is that so important?
Well, VASODILITATION RESULTS IN THIS HEAD FULLNESS THAT, I
WOULD SAY, 80 TO 90 PERCENT OF LONG-HAULERS TALK ABOUT. IT
CAUSES HEADACHES AND MIGRAINES. We think it causes brain fog,
tinnitus. It also causes, obviously, vasodilitation, hot/cold
insensitivity, low blood pressure which results in
compensatory heart rate increases. So you can account for a
lot of the symptoms in Covid long-haulers ... just by what
this interaction does on the endothelial walls. We call it in
a new paper, of course, "endothelitis," and of course we
intervene by using CCR5 antagonists, which prevent the
accumulation of these non-classical monocytes, and statins
which down-regulate the expression of fractalkine."